CN1647826A - Medical beta phase tricalcium phosphate/collagen cmposite material and its preparing method - Google Patents
Medical beta phase tricalcium phosphate/collagen cmposite material and its preparing method Download PDFInfo
- Publication number
- CN1647826A CN1647826A CN 200510049017 CN200510049017A CN1647826A CN 1647826 A CN1647826 A CN 1647826A CN 200510049017 CN200510049017 CN 200510049017 CN 200510049017 A CN200510049017 A CN 200510049017A CN 1647826 A CN1647826 A CN 1647826A
- Authority
- CN
- China
- Prior art keywords
- collagen
- tricalcium phosphate
- phase tricalcium
- solution
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The medical composite beta-tricalcium phosphate/collagen material consists of nano level beta-tricalcium phosphate in 50-67 wt% and collagen 33-50 wt%. Through in-situ complexing of collagen and beta-tricalcium phosphate, nanometer level beta-tricalcium phosphate powder is deposited on collagen substrate, and under the action of glutaraldehyde, the composite material has raised mechanical strength. The composite beta-tricalcium phosphate/collagen material of the present invention has homogeneous components, close combination, excellent biocompatibility, proper pore size and other features, and is suitable for use as the medical bone repairing material.
Description
Technical field
The present invention relates to a kind of medical β phase tricalcium phosphate/collagen composite materials and preparation method thereof, belong to the bio-medical technical field.
Background technology
Thunder bolt or disease make sclerous tissues such as people's skeleton, tooth produce damage or disappearance, thereby have formed the great market of medical repair materials.Usually, autotransplantation and homogeneous allogenic bone transplantation are used as the damaged scheme of treatment bone.But the source from the body bone is limited, can not be used for large-scale treatment; Though there is immunoreation in the allograph bone wide material sources, even viral communication may take place.Bone renovating material research has at present covered a plurality of fields that comprise metal, pottery, macromolecule and composite thereof, but these materials respectively have deficiency: what have retains for a long time in vivo, be easy to generate biological repelling effect, in time the increase in vivo that has, mechanical properties decrease is too fast, can not satisfy the requirement of bone renovating material.
Along with going deep into of research, people recognize that biodegradable bone renovating material is the trend of Future Development.Can be absorbed by the body fluid environment step by step after this material implants along with the prolongation of time, become the organic component of tissue alive, the risk of having avoided second operation to take out, and also the composition in the material can promote the generation organized.
Summary of the invention
The purpose of this invention is to provide a kind of β phase tricalcium phosphate finely dispersed degradable biological medical calcium phosphate/collagen composite materials and preparation method thereof in the collagen matrix.
Medical β phase tricalcium phosphate/collagen composite materials of the present invention is made up of nano beta phase tricalcium phosphate and collagen, and wherein the mass percentage content of β phase tricalcium phosphate is 50%～67%, and the mass percentage content of collagen is 50%～33%.
The preparation method of medical β phase tricalcium phosphate/collagen composite materials comprises the following steps:
1) be 1 * 10 with concentration
-4～10 * 10
-3The collagenolysis of g/ml stirs in pH value is 2～3 acid solution simultaneously, until forming milky white solution;
2) stirring evenly joins β phase tricalcium phosphate powder in the collagen solution down, and the β phase tricalcium phosphate of adding is 1: 1～2: 1 with the ratio of the quality of collagen;
3) stir that dropwise to add mass concentration down be 1% glutaraldehyde, the glutaraldehyde of adding is 1: 10 with the ratio of the quality of collagen;
4) continue stirring white cotton-shaped suspended material to occur in solution, stop to stir and leaving standstill, treat that flocculent substance all after the deposition, continues agitating solution, and dropwise drips aqueous slkali, is to stop to drip in 6～7 o'clock until pH value;
5) with solution left standstill, remove supernatant after, put into mould, freezing then, dry, put into ethanol and soak repeatedly, lyophilization once more, sterilization gets final product.
Among the present invention, the particle size of said β phase tricalcium phosphate is 200nm-500nm.The acid that is used to dissolve collagen can be hydrochloric acid or acetic acid.The aqueous slkali that drips can be NaOH, NH4OH or KOH.Step 5) is put into ethanol and is soaked repeatedly, and general 3～6 times, each 12～24h.
In order to reduce the cryodesiccated time of material, usually to adopt mould that the surface has a micropore for well.
The present invention has prepared medical β phase tricalcium phosphate/collagen composite materials in the mode of original position complexation, this material relies on the intermolecular group complexation to form by nanometer β phase tricalcium phosphate and tropocollagen molecule, on the collagen matrix, deposit β phase tricalcium phosphate powder, and under the effect of glutaraldehyde, increase the mechanical strength of composite.On micro-scale, have the characteristics that are evenly distributed.Under the freeze drying process condition, can prepare the bone renovating material of aperture size by this good biocompatibility, the β phase tricalcium phosphate/collagen composite materials of degrading completely, can be used as bio-medical material and aspect medical, be used widely in 10 μ m～150 μ m, hole internal communication.
The bone renovating material that adopts method of the present invention to prepare have uniform component distribution, β phase tricalcium phosphate and collagen in conjunction with closely, characteristics such as biocompatibility is good, finally degraded fully in vivo, do not have residuals to exist, can be used as embedded material and be applied in bio-medical fields such as bone tissue engineer.
Description of drawings
Fig. 1 is the stereoscan photograph of medical β phase tricalcium phosphate/collagen composite materials of making of embodiment 2.
The specific embodiment
Used collagen is the type i collagen that sigma company extracts from cattle root tendon in the following example.
Embodiment 1
1g collagen is dissolved in the hydrochloric acid solution of 300ml 0.01M, stir simultaneously, treat evenly to join 1.5g β phase tricalcium phosphate powder in the collagen solution after milky white solution forms, the glutaraldehyde solution that adds 10ml 1% then, continue to stir up to the cotton-shaped suspended material of white and occur, treat that it deposits back adding NaOH solution to pH value fully is 6, remove supernatant after leaving standstill 24h, the gained material is put into the surface has the mould of plastics of micropore to cool off 10min at liquid nitrogen, put into the dry 72h of freezer dryer then, put into ethanol after material takes out and soak 24h * 3 time, put into the dry 48h of freezer dryer once more, take out the back 2h that in oxirane steam, sterilizes.
Embodiment 2
0.4g collagen is dissolved in the acetic acid solution of 100ml 0.5M, stir simultaneously, treat evenly to join 0.8g β phase tricalcium phosphate powder in the collagen solution behind the milky white solution, the glutaraldehyde solution that adds 8ml 0.5% then, continuous stirring occurs up to the cotton-shaped suspended material of white, treats that it deposits the back fully and adds NH
4OH solution to pH value is 7, remove supernatant after leaving standstill 36h, the gained material is put into the surface has the mould of plastics of micropore to cool off 30min at liquid nitrogen, put into the dry 72h of freezer dryer then, put into ethanol after material takes out and soak 24h * 3 time, put into the dry 48h of freezer dryer once more, 3h sterilizes in oxirane steam after taking out.This example products therefrom is through sem test, and the material internal pattern is shown in legend 1, and from scheming as seen, the hole of the medical β phase tricalcium phosphate/collagen composite materials inside that makes is connected.
Embodiment 3
0.5g β phase tricalcium phosphate powder is evenly joined in the 400ml collagen solution, collagen solution concentration is 0.5mg/ml, the glutaraldehyde solution that adds 25ml 0.2% then, continue to stir up to the cotton-shaped suspended material of white and occur, treat that it deposits back adding KOH solution to pH value fully is 7, remove supernatant after leaving standstill 48h, the gained material is put into the surface has the mould of plastics of micropore to cool off 60min at liquid nitrogen, put into the dry 96h of freezer dryer then, put into ethanol after material takes out and soak 24h * 3 time, put into the dry 60h of freezer dryer once more, 1h sterilizes in oxirane steam after taking out.
Claims (3)
1. medical β phase tricalcium phosphate/collagen composite materials is characterized in that being made up of nano beta phase tricalcium phosphate and collagen, and wherein the mass percentage content of β phase tricalcium phosphate is 50%～67%, and the mass percentage content of collagen is 50%～33%.
2. according to right 1 described medical β phase tricalcium phosphate/collagen composite materials, the particle size that it is characterized in that nano beta phase tricalcium phosphate is 200nm-500nm.
3. according to the preparation method of right 1 described medical β phase tricalcium phosphate/collagen composite materials, it is characterized in that comprising the following steps:
1) be 1 * 10 with concentration
-4～10 * 10
-3The collagenolysis of g/ml stirs in pH value is 2～3 acid solution simultaneously, until forming milky white solution;
2) stirring evenly joins β phase tricalcium phosphate powder in the collagen solution down, and the β phase tricalcium phosphate of adding is 1: 1～2: 1 with the ratio of the quality of collagen;
3) stir that dropwise to add mass concentration down be 1% glutaraldehyde, the glutaraldehyde of adding is 1: 10 with the ratio of the quality of collagen;
4) continue stirring white cotton-shaped suspended material to occur in solution, stop to stir and leaving standstill, treat that flocculent substance all after the deposition, continues agitating solution, and dropwise drips aqueous slkali, is to stop to drip in 6～7 o'clock until pH value;
5) with solution left standstill, remove supernatant after, put into mould, freezing then, dry, put into ethanol and soak repeatedly, lyophilization once more, sterilization gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100490177A CN1329087C (en) | 2005-02-01 | 2005-02-01 | Medical beta phase tricalcium phosphate/collagen cmposite material and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100490177A CN1329087C (en) | 2005-02-01 | 2005-02-01 | Medical beta phase tricalcium phosphate/collagen cmposite material and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1647826A true CN1647826A (en) | 2005-08-03 |
| CN1329087C CN1329087C (en) | 2007-08-01 |
Family
ID=34876500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100490177A Expired - Fee Related CN1329087C (en) | 2005-02-01 | 2005-02-01 | Medical beta phase tricalcium phosphate/collagen cmposite material and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1329087C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101822852A (en) * | 2009-03-03 | 2010-09-08 | 北京化工大学 | Biomimetic calcium phosphate fiber composite bracket material and preparation method thereof |
| CN103055352A (en) * | 2013-01-22 | 2013-04-24 | 四川大学 | Calcium phosphate/collagen composite biologic ceramic material and preparation method thereof |
| CN107185040A (en) * | 2017-05-24 | 2017-09-22 | 成都大学 | The preparation method and its usage and usage of nano tricalcium phosphate hydrogel NTx biomaterial |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1338315A (en) * | 2001-10-12 | 2002-03-06 | 清华大学 | Process for preparing nm-crysal collagen-based calcium phosphate composition used for repairing bone |
| CN1328322C (en) * | 2005-01-27 | 2007-07-25 | 浙江大学 | Biodegradable calcium phosphate/collagen composite materials for medical use and method for preparation thereof |
-
2005
- 2005-02-01 CN CNB2005100490177A patent/CN1329087C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101822852A (en) * | 2009-03-03 | 2010-09-08 | 北京化工大学 | Biomimetic calcium phosphate fiber composite bracket material and preparation method thereof |
| CN101822852B (en) * | 2009-03-03 | 2013-04-10 | 北京化工大学 | Biomimetic calcium phosphate fiber composite bracket material and preparation method thereof |
| CN103055352A (en) * | 2013-01-22 | 2013-04-24 | 四川大学 | Calcium phosphate/collagen composite biologic ceramic material and preparation method thereof |
| CN103055352B (en) * | 2013-01-22 | 2014-12-10 | 四川大学 | Calcium phosphate/collagen composite biologic ceramic material and preparation method thereof |
| CN107185040A (en) * | 2017-05-24 | 2017-09-22 | 成都大学 | The preparation method and its usage and usage of nano tricalcium phosphate hydrogel NTx biomaterial |
| CN107185040B (en) * | 2017-05-24 | 2020-07-14 | 成都大学 | Preparation method, application and use of nano tricalcium phosphate-hydrogel-I type collagen biological material |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1329087C (en) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1328322C (en) | Biodegradable calcium phosphate/collagen composite materials for medical use and method for preparation thereof | |
| Janmohammadi et al. | Cellulose-based composite scaffolds for bone tissue engineering and localized drug delivery | |
| Yang et al. | 2D‐black‐phosphorus‐reinforced 3D‐printed scaffolds: a stepwise countermeasure for osteosarcoma | |
| Türk et al. | 3D porous collagen/functionalized multiwalled carbon nanotube/chitosan/hydroxyapatite composite scaffolds for bone tissue engineering | |
| Li et al. | Bioinspired mineralized collagen scaffolds for bone tissue engineering | |
| Muthukumar et al. | Collagen/chitosan porous bone tissue engineering composite scaffold incorporated with Ginseng compound K | |
| Nie et al. | Development of chitosan/gelatin hydrogels incorporation of biphasic calcium phosphate nanoparticles for bone tissue engineering | |
| Muzzarelli | Chitosan composites with inorganics, morphogenetic proteins and stem cells, for bone regeneration | |
| Venugopal et al. | Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering | |
| Shakir et al. | Resol based chitosan/nano-hydroxyapatite nanoensemble for effective bone tissue engineering | |
| CN105641753B (en) | A kind of 3D printing biodegradable stent of the achievable blood vessel transfer of compound rhBMP-2 | |
| CN1301137C (en) | Silk fibrin and hydroxyapatite compound material and preparation process thereof | |
| CN108203448A (en) | Promote mineralising and the injection aquagel of the sustained release of bioactive ions is provided | |
| Ye et al. | Rapid biomimetic mineralization of collagen fibrils and combining with human umbilical cord mesenchymal stem cells for bone defects healing | |
| CN105148324A (en) | Bone bionic materials built by mineralized nano cellulose whiskers and production method of bone bionic materials | |
| Mahdavi et al. | Avian egg: a multifaceted biomaterial for tissue engineering | |
| CN100404079C (en) | Biotic bone tissue engineering stent and its preparation method | |
| CN105521525A (en) | Porous composite scaffold for bone tissue engineering and preparation method therefor | |
| Yang et al. | Facile mussel-inspired polymerization to facilitate biomimetic in situ homogeneous mineralization for bone regeneration | |
| CN1329087C (en) | Medical beta phase tricalcium phosphate/collagen cmposite material and its preparing method | |
| Ramalingam et al. | Biomimetics: advancing nanobiomaterials and tissue engineering | |
| Gao et al. | Porous cellulose microspheres coated in one step with a polydopamine suspension of hydroxyapatite for bone tissue engineering | |
| Flores Valdez et al. | Hydroxyapatite and biopolymer composites with promising biomedical applications | |
| Shi et al. | Fabrication, properties, and biomedical applications of calcium-containing cellulose-based composites | |
| Guerra et al. | Chitosan‐Based Macromolecular Biomaterials for the Regeneration of Chondroskeletal and Nerve Tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070801 Termination date: 20100201 |